Paul E. Sax, M.D., is director of the HIV Program and Division of Infectious Diseases at Brigham and Women's Hospital in Boston.
The folks over at the Journal of the American Medical Association have been doing a periodic HIV/AIDS themed issue for years, generally around the time of the International AIDS Conference.
The latest issue is out this week, and it's terrific. Here are some highlights:
In serodiscordant couples practicing "condomless sex", there were zero transmissions if the infected partner was on suppressive HIV therapy. If you're keeping score, the estimated number of sexual contacts in this ambitious cohort study was 58,000 (36,000 heterosexual, 22,000 MSM). Statistically-inclined nerds will point out that you can't really say the risk is zero -- there's a 95% confidence interval around this zero estimate, you can read the upper limit in the full paper, both for the heterosexual and MSM groups. Plus, with a median f/u of only 1-2 years, of course further study is required for a more precise estimate of risk. Despite these limitations and others -- well-described in the excellent accompanying editorial -- we all must admit that ZERO transmissions to date is a very good start! And we should heartily thank the study investigators for introducing a nifty new word to the medical/ID lexicon -- "condomless" is vastly preferable "acondomic" or "condomopenic", though that last one might make more people smile.
For our most challenging patients, providing "patient navigation" and financial incentives did not improve virologic suppression rates compared with standard-of-care.The inclusion criteria for participation in this study were just the things that usually exclude patients from other trials -- they were hospitalized, with addiction, psychiatric disease, had poor compliance with ART, terrible outpatient follow-up -- you get the idea, challenging. They were randomized to 1) usual care; 2) "patient navigation" (intensive case management); 3) patient navigation plus financial incentives. During the 6 month intervention, virologic outcomes were better in the patient navigation/financial incentives group, but 6 months after the interventions stopped the benefit wore off. I guess "pay for performance" works, but only while someone is paying! A fascinating and remarkable study.
Hey, remember when JAMA had art on the cover? (And yes, I miss that.) The 1996 cover to the HIV/AIDS issue was famously blank (see image above), the absence of artwork making a strong statement about "the toll the virus has taken among artists and other creative persons who have died prematurely because of AIDS."
Now, 20 years later, the current HIV/AIDS JAMA issue includes content that would have been unfathomable at that time. Little did we know that 1996 would be the pivotal year, the turning point when this rapidly fatal disease -- then the leading cause of death among young Americans -- would become both treatable and preventable.
Even "augmented reality" can't compete.
(I predict 2-3 months for this Pokemon Go craze, but what do I know.)
(Please note: Your name and comment will be public, and may even show up in Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.)
HIV Care Today is a multi-author blog featuring people on the frontlines of HIV treatment, prevention and patient/client care. This blog serves as a platform for these health care professionals to discuss the everyday challenges of their jobs, recent developments in their fields and issues relevant to the evolution of HIV/AIDS care.
TheBodyPRO is a service of Remedy Health Media, 461 Fifth Avenue, 14th Floor, New York, NY 10017. TheBodyPRO and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.